APO Research
Talk to an analyst

APO RESEARCH · REPORT

Butorphanol

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Butorphanol Market Outlook and Growth Opportunities 2026

19 December 2025201 pages

Choose your research edition.

Industry ResearchButorphanol Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Butorphanol Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Butorphanol Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Butorphanol Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Butorphanol Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Butorphanol market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Butorphanol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Butorphanol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Butorphanol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Butorphanol market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Butorphanol market include Zoetis, Merck KGaA, Mylan, Pfizer, Troy Laboratories Nz, Selectavet, Sanochemia Pharmazeutika, Richter Pharma Ag and Novex Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Butorphanol market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Butorphanol and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Butorphanol sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Butorphanol market size, projected growth trends, production technologies, key applications, and end-use industries.

Butorphanol Segment by Company

Zoetis

Merck KGaA

Mylan

Pfizer

Troy Laboratories Nz

Selectavet

Sanochemia Pharmazeutika

Richter Pharma Ag

Novex Pharma

Hikma Pharmaceuticals

Faunapharma

Dechra Pharmaceuticals

Bristol Myers Squibb

Boehringer Ingelheim Santé Animale

Ausrichter

Athanas Enterprise Private Limited

Apothecon Pharmaceuticals

Animedica

Butorphanol Segment by Type

Injection

Spray

Tablet

Butorphanol Segment by Application

Human

Veterinary

Butorphanol Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Butorphanol status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Butorphanol market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Butorphanol significant trends, drivers, influence factors in global and regions.

6. To analyze Butorphanol competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Butorphanol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Butorphanol and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Butorphanol.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Butorphanol market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Butorphanol industry.

Chapter 3: Detailed analysis of Butorphanol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Butorphanol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Butorphanol in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Butorphanol Industry Trends Table 2. Butorphanol Industry Drivers Table 3. Butorphanol Industry Opportunities and Challenges Table 4. Butorphanol Industry Restraints Table 5. Global Butorphanol Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Butorphanol Revenue Share by Company (2021-2026) Table 7. Global Butorphanol Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Butorphanol Sales Volume Share by Company (2021-2026) Table 9. Global Butorphanol Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Butorphanol Company Ranking, (2024-2026) & (USD Million) Table 11. Global Butorphanol Key Company Manufacturing Base & Headquarters Table 12. Global Butorphanol Company, Product Type & Application Table 13. Global Butorphanol Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Butorphanol by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Injection Table 18. Significant Companies of Spray Table 19. Significant Companies of Tablet Table 20. Global Butorphanol Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Butorphanol Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Butorphanol Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Butorphanol Sales Volume Share by Type (2021-2026) Table 24. Global Butorphanol Sales Volume Share by Type (2027-2032) Table 25. Global Butorphanol Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Butorphanol Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Butorphanol Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Butorphanol Sales Value Share by Type (2021-2026) Table 29. Global Butorphanol Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Human Table 31. Significant Companies of Veterinary Table 32. Global Butorphanol Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Butorphanol Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Butorphanol Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Butorphanol Sales Volume Share by Application (2021-2026) Table 36. Global Butorphanol Sales Volume Share by Application (2027-2032) Table 37. Global Butorphanol Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Butorphanol Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Butorphanol Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Butorphanol Sales Value Share by Application (2021-2026) Table 41. Global Butorphanol Sales Value Share by Application (2027-2032) Table 42. Global Butorphanol Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Butorphanol Sales by Region (2021-2026) & (K Units) Table 44. Global Butorphanol Sales Market Share by Region (2021-2026) Table 45. Global Butorphanol Sales by Region (2027-2032) & (K Units) Table 46. Global Butorphanol Sales Market Share by Region (2027-2032) Table 47. Global Butorphanol Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Butorphanol Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Butorphanol Sales Value Share by Region (2021-2026) Table 50. Global Butorphanol Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Butorphanol Sales Value Share by Region (2027-2032) Table 52. Global Butorphanol Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Butorphanol Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Butorphanol Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Butorphanol Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Butorphanol Sales by Country (2021-2026) & (K Units) Table 57. Global Butorphanol Sales Market Share by Country (2021-2026) Table 58. Global Butorphanol Sales by Country (2027-2032) & (K Units) Table 59. Global Butorphanol Sales Market Share by Country (2027-2032) Table 60. Global Butorphanol Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Butorphanol Sales Value Market Share by Country (2021-2026) Table 62. Global Butorphanol Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Butorphanol Sales Value Market Share by Country (2027-2032) Table 64. Zoetis Company Information Table 65. Zoetis Business Overview Table 66. Zoetis Butorphanol Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Zoetis Butorphanol Product Portfolio Table 68. Zoetis Recent Development Table 69. Merck KGaA Company Information Table 70. Merck KGaA Business Overview Table 71. Merck KGaA Butorphanol Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Merck KGaA Butorphanol Product Portfolio Table 73. Merck KGaA Recent Development Table 74. Mylan Company Information Table 75. Mylan Business Overview Table 76. Mylan Butorphanol Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Mylan Butorphanol Product Portfolio Table 78. Mylan Recent Development Table 79. Pfizer Company Information Table 80. Pfizer Business Overview Table 81. Pfizer Butorphanol Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Pfizer Butorphanol Product Portfolio Table 83. Pfizer Recent Development Table 84. Troy Laboratories Nz Company Information Table 85. Troy Laboratories Nz Business Overview Table 86. Troy Laboratories Nz Butorphanol Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Troy Laboratories Nz Butorphanol Product Portfolio Table 88. Troy Laboratories Nz Recent Development Table 89. Selectavet Company Information Table 90. Selectavet Business Overview Table 91. Selectavet Butorphanol Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Selectavet Butorphanol Product Portfolio Table 93. Selectavet Recent Development Table 94. Sanochemia Pharmazeutika Company Information Table 95. Sanochemia Pharmazeutika Business Overview Table 96. Sanochemia Pharmazeutika Butorphanol Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Sanochemia Pharmazeutika Butorphanol Product Portfolio Table 98. Sanochemia Pharmazeutika Recent Development Table 99. Richter Pharma Ag Company Information Table 100. Richter Pharma Ag Business Overview Table 101. Richter Pharma Ag Butorphanol Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Richter Pharma Ag Butorphanol Product Portfolio Table 103. Richter Pharma Ag Recent Development Table 104. Novex Pharma Company Information Table 105. Novex Pharma Business Overview Table 106. Novex Pharma Butorphanol Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Novex Pharma Butorphanol Product Portfolio Table 108. Novex Pharma Recent Development Table 109. Hikma Pharmaceuticals Company Information Table 110. Hikma Pharmaceuticals Business Overview Table 111. Hikma Pharmaceuticals Butorphanol Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Hikma Pharmaceuticals Butorphanol Product Portfolio Table 113. Hikma Pharmaceuticals Recent Development Table 114. Faunapharma Company Information Table 115. Faunapharma Business Overview Table 116. Faunapharma Butorphanol Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Faunapharma Butorphanol Product Portfolio Table 118. Faunapharma Recent Development Table 119. Dechra Pharmaceuticals Company Information Table 120. Dechra Pharmaceuticals Business Overview Table 121. Dechra Pharmaceuticals Butorphanol Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Dechra Pharmaceuticals Butorphanol Product Portfolio Table 123. Dechra Pharmaceuticals Recent Development Table 124. Bristol Myers Squibb Company Information Table 125. Bristol Myers Squibb Business Overview Table 126. Bristol Myers Squibb Butorphanol Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Bristol Myers Squibb Butorphanol Product Portfolio Table 128. Bristol Myers Squibb Recent Development Table 129. Boehringer Ingelheim Santé Animale Company Information Table 130. Boehringer Ingelheim Santé Animale Business Overview Table 131. Boehringer Ingelheim Santé Animale Butorphanol Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Boehringer Ingelheim Santé Animale Butorphanol Product Portfolio Table 133. Boehringer Ingelheim Santé Animale Recent Development Table 134. Ausrichter Company Information Table 135. Ausrichter Business Overview Table 136. Ausrichter Butorphanol Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Ausrichter Butorphanol Product Portfolio Table 138. Ausrichter Recent Development Table 139. Athanas Enterprise Private Limited Company Information Table 140. Athanas Enterprise Private Limited Business Overview Table 141. Athanas Enterprise Private Limited Butorphanol Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Athanas Enterprise Private Limited Butorphanol Product Portfolio Table 143. Athanas Enterprise Private Limited Recent Development Table 144. Apothecon Pharmaceuticals Company Information Table 145. Apothecon Pharmaceuticals Business Overview Table 146. Apothecon Pharmaceuticals Butorphanol Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Apothecon Pharmaceuticals Butorphanol Product Portfolio Table 148. Apothecon Pharmaceuticals Recent Development Table 149. Animedica Company Information Table 150. Animedica Business Overview Table 151. Animedica Butorphanol Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Animedica Butorphanol Product Portfolio Table 153. Animedica Recent Development Table 154. Key Raw Materials Table 155. Raw Materials Key Suppliers Table 156. Butorphanol Distributors List Table 157. Butorphanol Customers List Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources Table 161. Primary Sources List of Figures Figure 1. Butorphanol Product Image Figure 2. Global Butorphanol Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Butorphanol Sales Value (2021-2032) & (US$ Million) Figure 4. Global Butorphanol Sales (2021-2032) & (K Units) Figure 5. Global Butorphanol Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Butorphanol Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Injection Image Figure 10. Spray Image Figure 11. Tablet Image Figure 12. Global Butorphanol Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Butorphanol Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Butorphanol Sales Volume Share by Type (2021-2032) Figure 15. Global Butorphanol Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Butorphanol Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Butorphanol Sales Value Share by Type (2021-2032) Figure 18. Human Image Figure 19. Veterinary Image Figure 20. Global Butorphanol Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Butorphanol Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Butorphanol Sales Volume Share by Application (2021-2032) Figure 23. Global Butorphanol Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Butorphanol Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Butorphanol Sales Value Share by Application (2021-2032) Figure 26. Global Butorphanol Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Butorphanol Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Butorphanol Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Butorphanol Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Butorphanol Sales Value (2021-2032) & (US$ Million) Figure 31. North America Butorphanol Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Butorphanol Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Butorphanol Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Butorphanol Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Butorphanol Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Butorphanol Sales Value (2021-2032) & (US$ Million) Figure 37. South America Butorphanol Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Butorphanol Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Butorphanol Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Butorphanol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Butorphanol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Butorphanol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Butorphanol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Butorphanol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Butorphanol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Butorphanol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Butorphanol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Butorphanol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Butorphanol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Butorphanol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Butorphanol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Butorphanol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Butorphanol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Butorphanol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Butorphanol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Butorphanol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Butorphanol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Butorphanol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Butorphanol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Butorphanol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Butorphanol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Butorphanol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Butorphanol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Butorphanol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Butorphanol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Butorphanol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Butorphanol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Butorphanol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Butorphanol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Butorphanol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Butorphanol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Butorphanol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Butorphanol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Butorphanol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Butorphanol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Butorphanol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Butorphanol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Butorphanol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Butorphanol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Butorphanol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Butorphanol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Butorphanol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Butorphanol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Butorphanol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Butorphanol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Butorphanol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Butorphanol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Butorphanol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Butorphanol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Butorphanol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Butorphanol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Butorphanol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Butorphanol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Butorphanol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Butorphanol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Butorphanol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Butorphanol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Butorphanol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Butorphanol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Butorphanol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Butorphanol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Butorphanol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Butorphanol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Butorphanol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Butorphanol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Butorphanol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Butorphanol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Butorphanol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Butorphanol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Butorphanol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Butorphanol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Butorphanol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Butorphanol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Butorphanol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Butorphanol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Butorphanol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Butorphanol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Butorphanol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Butorphanol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Butorphanol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Butorphanol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Butorphanol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Butorphanol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Butorphanol Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Butorphanol Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Spray
  • Tablet
Applications
  • Human
  • Veterinary
Companies covered
  • Zoetis
  • Merck KGaA
  • Mylan
  • Pfizer
  • Troy Laboratories Nz
  • Selectavet
  • Sanochemia Pharmazeutika
  • Richter Pharma Ag
  • Novex Pharma
  • Hikma Pharmaceuticals
  • Faunapharma
  • Dechra Pharmaceuticals
  • Bristol Myers Squibb
  • Boehringer Ingelheim Santé Animale
  • Ausrichter
  • Athanas Enterprise Private Limited
  • Apothecon Pharmaceuticals
  • Animedica

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Butorphanol Sales Value (2021-2032)
  4. 1.2.2 Global Butorphanol Sales Volume (2021-2032)
  5. 1.2.3 Global Butorphanol Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Butorphanol Market Dynamics
  1. 2.1 Butorphanol Industry Trends
  2. 2.2 Butorphanol Industry Drivers
  3. 2.3 Butorphanol Industry Opportunities and Challenges
  4. 2.4 Butorphanol Industry Restraints
3 Butorphanol Market by Company
  1. 3.1 Global Butorphanol Company Revenue Ranking in 2025
  2. 3.2 Global Butorphanol Revenue by Company (2021-2026)
  3. 3.3 Global Butorphanol Sales Volume by Company (2021-2026)
  4. 3.4 Global Butorphanol Average Price by Company (2021-2026)
  5. 3.5 Global Butorphanol Company Ranking (2024-2026)
  6. 3.6 Global Butorphanol Company Manufacturing Base and Headquarters
  7. 3.7 Global Butorphanol Company Product Type and Application
  8. 3.8 Global Butorphanol Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Butorphanol Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Butorphanol Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Butorphanol Market by Type
  1. 4.1 Butorphanol Type Introduction
  2. 4.1.1 Injection
  3. 4.1.2 Spray
  4. 4.1.3 Tablet
  5. 4.2 Global Butorphanol Sales Volume by Type
  6. 4.2.1 Global Butorphanol Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Butorphanol Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Butorphanol Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Butorphanol Sales Value by Type
  10. 4.3.1 Global Butorphanol Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Butorphanol Sales Value by Type (2021-2032)
  12. 4.3.3 Global Butorphanol Sales Value Share by Type (2021-2032)
5 Butorphanol Market by Application
  1. 5.1 Butorphanol Application Introduction
  2. 5.1.1 Human
  3. 5.1.2 Veterinary
  4. 5.2 Global Butorphanol Sales Volume by Application
  5. 5.2.1 Global Butorphanol Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Butorphanol Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Butorphanol Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Butorphanol Sales Value by Application
  9. 5.3.1 Global Butorphanol Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Butorphanol Sales Value by Application (2021-2032)
  11. 5.3.3 Global Butorphanol Sales Value Share by Application (2021-2032)
6 Butorphanol Regional Sales and Value Analysis
  1. 6.1 Global Butorphanol Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Butorphanol Sales by Region (2021-2032)
  3. 6.2.1 Global Butorphanol Sales by Region: 2021-2026
  4. 6.2.2 Global Butorphanol Sales by Region (2027-2032)
  5. 6.3 Global Butorphanol Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Butorphanol Sales Value by Region (2021-2032)
  7. 6.4.1 Global Butorphanol Sales Value by Region: 2021-2026
  8. 6.4.2 Global Butorphanol Sales Value by Region (2027-2032)
  9. 6.5 Global Butorphanol Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Butorphanol Sales Value (2021-2032)
  12. 6.6.2 North America Butorphanol Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Butorphanol Sales Value (2021-2032)
  15. 6.7.2 Europe Butorphanol Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Butorphanol Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Butorphanol Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Butorphanol Sales Value (2021-2032)
  21. 6.9.2 South America Butorphanol Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Butorphanol Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Butorphanol Sales Value Share by Country, 2025 VS 2032
7 Butorphanol Country-level Sales and Value Analysis
  1. 7.1 Global Butorphanol Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Butorphanol Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Butorphanol Sales by Country (2021-2032)
  4. 7.3.1 Global Butorphanol Sales by Country (2021-2026)
  5. 7.3.2 Global Butorphanol Sales by Country (2027-2032)
  6. 7.4 Global Butorphanol Sales Value by Country (2021-2032)
  7. 7.4.1 Global Butorphanol Sales Value by Country (2021-2026)
  8. 7.4.2 Global Butorphanol Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Butorphanol Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Butorphanol Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Butorphanol Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Butorphanol Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Butorphanol Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Butorphanol Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Butorphanol Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Butorphanol Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Butorphanol Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Butorphanol Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Butorphanol Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Butorphanol Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Butorphanol Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Butorphanol Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Butorphanol Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Butorphanol Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Butorphanol Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Butorphanol Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Butorphanol Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Butorphanol Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Butorphanol Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Butorphanol Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Butorphanol Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Butorphanol Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Butorphanol Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Butorphanol Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Butorphanol Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Butorphanol Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Butorphanol Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Butorphanol Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Butorphanol Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Butorphanol Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Butorphanol Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Butorphanol Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Butorphanol Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Butorphanol Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Butorphanol Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Butorphanol Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Butorphanol Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Butorphanol Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Butorphanol Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Butorphanol Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Butorphanol Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Butorphanol Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Butorphanol Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Butorphanol Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Butorphanol Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Butorphanol Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Butorphanol Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Butorphanol Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Butorphanol Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Butorphanol Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Butorphanol Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Butorphanol Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Butorphanol Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Butorphanol Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Butorphanol Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Butorphanol Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Butorphanol Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Butorphanol Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Butorphanol Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Butorphanol Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Butorphanol Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Butorphanol Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Butorphanol Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Butorphanol Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Butorphanol Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Butorphanol Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Butorphanol Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Butorphanol Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Butorphanol Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Butorphanol Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Butorphanol Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Butorphanol Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Butorphanol Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Butorphanol Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Butorphanol Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Butorphanol Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Butorphanol Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Butorphanol Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Butorphanol Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Butorphanol Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Butorphanol Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Butorphanol Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Butorphanol Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Butorphanol Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Merck KGaA
  8. 8.2.1 Merck KGaA Company Information
  9. 8.2.2 Merck KGaA Business Overview
  10. 8.2.3 Merck KGaA Butorphanol Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck KGaA Butorphanol Product Portfolio
  12. 8.2.5 Merck KGaA Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan Butorphanol Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Butorphanol Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Butorphanol Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Butorphanol Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Troy Laboratories Nz
  26. 8.5.1 Troy Laboratories Nz Company Information
  27. 8.5.2 Troy Laboratories Nz Business Overview
  28. 8.5.3 Troy Laboratories Nz Butorphanol Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Troy Laboratories Nz Butorphanol Product Portfolio
  30. 8.5.5 Troy Laboratories Nz Recent Developments
  31. 8.6 Selectavet
  32. 8.6.1 Selectavet Company Information
  33. 8.6.2 Selectavet Business Overview
  34. 8.6.3 Selectavet Butorphanol Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Selectavet Butorphanol Product Portfolio
  36. 8.6.5 Selectavet Recent Developments
  37. 8.7 Sanochemia Pharmazeutika
  38. 8.7.1 Sanochemia Pharmazeutika Company Information
  39. 8.7.2 Sanochemia Pharmazeutika Business Overview
  40. 8.7.3 Sanochemia Pharmazeutika Butorphanol Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Sanochemia Pharmazeutika Butorphanol Product Portfolio
  42. 8.7.5 Sanochemia Pharmazeutika Recent Developments
  43. 8.8 Richter Pharma Ag
  44. 8.8.1 Richter Pharma Ag Company Information
  45. 8.8.2 Richter Pharma Ag Business Overview
  46. 8.8.3 Richter Pharma Ag Butorphanol Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Richter Pharma Ag Butorphanol Product Portfolio
  48. 8.8.5 Richter Pharma Ag Recent Developments
  49. 8.9 Novex Pharma
  50. 8.9.1 Novex Pharma Company Information
  51. 8.9.2 Novex Pharma Business Overview
  52. 8.9.3 Novex Pharma Butorphanol Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Novex Pharma Butorphanol Product Portfolio
  54. 8.9.5 Novex Pharma Recent Developments
  55. 8.10 Hikma Pharmaceuticals
  56. 8.10.1 Hikma Pharmaceuticals Company Information
  57. 8.10.2 Hikma Pharmaceuticals Business Overview
  58. 8.10.3 Hikma Pharmaceuticals Butorphanol Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Hikma Pharmaceuticals Butorphanol Product Portfolio
  60. 8.10.5 Hikma Pharmaceuticals Recent Developments
  61. 8.11 Faunapharma
  62. 8.11.1 Faunapharma Company Information
  63. 8.11.2 Faunapharma Business Overview
  64. 8.11.3 Faunapharma Butorphanol Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Faunapharma Butorphanol Product Portfolio
  66. 8.11.5 Faunapharma Recent Developments
  67. 8.12 Dechra Pharmaceuticals
  68. 8.12.1 Dechra Pharmaceuticals Company Information
  69. 8.12.2 Dechra Pharmaceuticals Business Overview
  70. 8.12.3 Dechra Pharmaceuticals Butorphanol Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Dechra Pharmaceuticals Butorphanol Product Portfolio
  72. 8.12.5 Dechra Pharmaceuticals Recent Developments
  73. 8.13 Bristol Myers Squibb
  74. 8.13.1 Bristol Myers Squibb Company Information
  75. 8.13.2 Bristol Myers Squibb Business Overview
  76. 8.13.3 Bristol Myers Squibb Butorphanol Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Bristol Myers Squibb Butorphanol Product Portfolio
  78. 8.13.5 Bristol Myers Squibb Recent Developments
  79. 8.14 Boehringer Ingelheim Santé Animale
  80. 8.14.1 Boehringer Ingelheim Santé Animale Company Information
  81. 8.14.2 Boehringer Ingelheim Santé Animale Business Overview
  82. 8.14.3 Boehringer Ingelheim Santé Animale Butorphanol Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Boehringer Ingelheim Santé Animale Butorphanol Product Portfolio
  84. 8.14.5 Boehringer Ingelheim Santé Animale Recent Developments
  85. 8.15 Ausrichter
  86. 8.15.1 Ausrichter Company Information
  87. 8.15.2 Ausrichter Business Overview
  88. 8.15.3 Ausrichter Butorphanol Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Ausrichter Butorphanol Product Portfolio
  90. 8.15.5 Ausrichter Recent Developments
  91. 8.16 Athanas Enterprise Private Limited
  92. 8.16.1 Athanas Enterprise Private Limited Company Information
  93. 8.16.2 Athanas Enterprise Private Limited Business Overview
  94. 8.16.3 Athanas Enterprise Private Limited Butorphanol Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Athanas Enterprise Private Limited Butorphanol Product Portfolio
  96. 8.16.5 Athanas Enterprise Private Limited Recent Developments
  97. 8.17 Apothecon Pharmaceuticals
  98. 8.17.1 Apothecon Pharmaceuticals Company Information
  99. 8.17.2 Apothecon Pharmaceuticals Business Overview
  100. 8.17.3 Apothecon Pharmaceuticals Butorphanol Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Apothecon Pharmaceuticals Butorphanol Product Portfolio
  102. 8.17.5 Apothecon Pharmaceuticals Recent Developments
  103. 8.18 Animedica
  104. 8.18.1 Animedica Company Information
  105. 8.18.2 Animedica Business Overview
  106. 8.18.3 Animedica Butorphanol Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Animedica Butorphanol Product Portfolio
  108. 8.18.5 Animedica Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Butorphanol Value Chain Analysis
  2. 9.1.1 Butorphanol Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Butorphanol Sales Mode & Process
  6. 9.2 Butorphanol Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Butorphanol Distributors
  9. 9.2.3 Butorphanol Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst